Published in Nephrol Dial Transplant on January 08, 2008
The influence of gender and sexual hormones on incidence and outcome of chronic kidney disease. Pediatr Nephrol (2011) 2.13
The natural history of the non-nephrotic membranous nephropathy patient. Clin J Am Soc Nephrol (2009) 1.23
The genetics and immunobiology of IgA nephropathy. J Clin Invest (2014) 1.22
Clinical outcomes and predictors for ESRD and mortality in primary GN. Clin J Am Soc Nephrol (2012) 1.04
A molecular signature of proteinuria in glomerulonephritis. PLoS One (2010) 1.03
HLA-DQA1 and PLA2R1 polymorphisms and risk of idiopathic membranous nephropathy. Clin J Am Soc Nephrol (2013) 0.95
M-type phospholipase A2 receptor autoantibodies and renal function in patients with primary membranous nephropathy. Clin J Am Soc Nephrol (2014) 0.94
Estrogen receptor alpha expression in podocytes mediates protection against apoptosis in-vitro and in-vivo. PLoS One (2011) 0.91
Identifying the ideal metric of proteinuria as a predictor of renal outcome in idiopathic glomerulonephritis. Kidney Int (2015) 0.90
Complete and Partial Remission as Surrogate End Points in Membranous Nephropathy. J Am Soc Nephrol (2015) 0.89
Gender effect on renal outcome in patients with urothelial carcinoma. World J Urol (2011) 0.86
Urinary MicroRNA Profiling Predicts the Development of Microalbuminuria in Patients with Type 1 Diabetes. J Clin Med (2015) 0.82
Gender difference in albuminuria and ischemic heart disease in type 2 diabetes. Clin Med Res (2011) 0.80
Association of rs1800471 polymorphism of TGFB1 gene with chronic kidney disease occurrence and progression and hypertension appearance. Arch Med Sci (2013) 0.80
Optimal proteinuria target for renoprotection in patients with IgA nephropathy. PLoS One (2014) 0.78
Chapter 7: Idiopathic membranous nephropathy. Kidney Int Suppl (2011) (2012) 0.78
Membranous nephropathy: Treatment outline and risk stratification. Avicenna J Med (2012) 0.77
Continental variations in IgA nephropathy among Asians. Clin Nephrol (2008) 0.77
Management of Membranous Nephropathy in Western Countries. Kidney Dis (Basel) (2015) 0.75
Influence of Normo- and Hypogonadal Condition, Hyperuricemia, and High-Fructose Diet on Renal Changes in Male Rats. Int J Endocrinol (2017) 0.75
Combination therapy with rituximab, low-dose cyclophosphamide, and prednisone for idiopathic membranous nephropathy: a case series. BMC Nephrol (2017) 0.75
Inverse associations between androgens and renal function: the Young Men Cardiovascular Association (YMCA) study. Am J Hypertens (2008) 0.75
Gender Differences in the Acute Kidney Injury to Chronic Kidney Disease Transition. Sci Rep (2017) 0.75
The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Kidney Int (2009) 7.45
The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility. Kidney Int (2009) 7.19
Remission of proteinuria improves prognosis in IgA nephropathy. J Am Soc Nephrol (2007) 3.66
Immunostaining findings in IgA nephropathy: correlation with histology and clinical outcome in the Oxford classification patient cohort. Nephrol Dial Transplant (2011) 2.51
Focal and segmental glomerulosclerosis: definition and relevance of a partial remission. J Am Soc Nephrol (2005) 2.25
Venous thromboembolism in patients with membranous nephropathy. Clin J Am Soc Nephrol (2011) 2.18
The Oxford IgA nephropathy clinicopathological classification is valid for children as well as adults. Kidney Int (2010) 2.14
Decreased glomerular and tubular expression of ACE2 in patients with type 2 diabetes and kidney disease. Kidney Int (2008) 1.99
Gender differences in the renal response to renin-angiotensin system blockade. J Am Soc Nephrol (2006) 1.91
Regression of left ventricular hypertrophy after conversion to nocturnal hemodialysis. Kidney Int (2002) 1.88
Human recombinant ACE2 reduces the progression of diabetic nephropathy. Diabetes (2009) 1.78
Pentastarch 10% (250 kDa/0.45) is an independent risk factor of acute kidney injury following cardiac surgery. Crit Care Med (2009) 1.76
Design of the Nephrotic Syndrome Study Network (NEPTUNE) to evaluate primary glomerular nephropathy by a multidisciplinary approach. Kidney Int (2013) 1.69
Angiotensin 1-7 mediates renoprotection against diabetic nephropathy by reducing oxidative stress, inflammation, and lipotoxicity. Am J Physiol Renal Physiol (2014) 1.64
Individuals of Pacific Asian origin with IgA nephropathy have an increased risk of progression to end-stage renal disease. Kidney Int (2013) 1.63
Persistent proteinuria and dyslipidemia increase the risk of progressive chronic kidney disease in lupus erythematosus. Kidney Int (2011) 1.63
Idiopathic membranous nephropathy: definition and relevance of a partial remission. Kidney Int (2004) 1.62
EGFR dinucleotide repeat polymorphism as a prognostic indicator in non-small cell lung cancer. J Thorac Oncol (2006) 1.57
Molecular markers of injury in kidney biopsy specimens of patients with lupus nephritis. J Mol Diagn (2011) 1.57
Loss of angiotensin-converting enzyme-2 (Ace2) accelerates diabetic kidney injury. Am J Pathol (2007) 1.55
Validation of the Oxford classification of IgA nephropathy. Kidney Int (2011) 1.53
Endothelial nitric oxide synthase gene polymorphisms and the renal hemodynamic response to L-arginine. Kidney Int (2008) 1.50
Prevention of angiotensin II-mediated renal oxidative stress, inflammation, and fibrosis by angiotensin-converting enzyme 2. Hypertension (2010) 1.45
Angiotensin II-mediated oxidative stress and inflammation mediate the age-dependent cardiomyopathy in ACE2 null mice. Cardiovasc Res (2007) 1.40
Impact of an exercise program on arterial stiffness and insulin resistance in hemodialysis patients. J Am Soc Nephrol (2004) 1.36
Impact of renin angiotensin system modulation on the hyperfiltration state in type 1 diabetes. J Am Soc Nephrol (2006) 1.35
Loss of angiotensin-converting enzyme-2 leads to the late development of angiotensin II-dependent glomerulosclerosis. Am J Pathol (2006) 1.35
Risk perception and compliance with quarantine during the SARS outbreak. J Nurs Scholarsh (2005) 1.34
A multicenter application and evaluation of the oxford classification of IgA nephropathy in adult chinese patients. Am J Kidney Dis (2012) 1.32
Loss of angiotensin-converting enzyme 2 accelerates maladaptive left ventricular remodeling in response to myocardial infarction. Circ Heart Fail (2009) 1.29
Risk stratification of patients with IgA nephropathy. Am J Kidney Dis (2012) 1.25
The effect of cyclooxygenase-2 inhibition on renal hemodynamic function in humans with type 1 diabetes. Diabetes (2007) 1.24
Short-term blood pressure, noradrenergic, and vascular effects of nocturnal home hemodialysis. Hypertension (2003) 1.23
Improvement in ejection fraction by nocturnal haemodialysis in end-stage renal failure patients with coexisting heart failure. Nephrol Dial Transplant (2002) 1.22
Have we changed the outcome in membranous nephropathy? A propensity study on the role of immunosuppressive therapy. Clin J Am Soc Nephrol (2011) 1.18
Flux through the hexosamine pathway is a determinant of nuclear factor kappaB- dependent promoter activation. Diabetes (2002) 1.17
Effect of direct renin inhibition on renal hemodynamic function, arterial stiffness, and endothelial function in humans with uncomplicated type 1 diabetes: a pilot study. Diabetes Care (2009) 1.17
Evaluation of the Oxford Classification of IgA nephropathy: a systematic review and meta-analysis. Am J Kidney Dis (2013) 1.17
Oxidative stress and galactose-deficient IgA1 as markers of progression in IgA nephropathy. Clin J Am Soc Nephrol (2011) 1.14
Disease-specific risk of venous thromboembolic events is increased in idiopathic glomerulonephritis. Kidney Int (2011) 1.13
Variation in the renin angiotensin system throughout the normal menstrual cycle. J Am Soc Nephrol (2002) 1.11
Loss of PTEN attenuates the development of pathological hypertrophy and heart failure in response to biomechanical stress. Cardiovasc Res (2008) 1.11
Loss of TIMP3 enhances interstitial nephritis and fibrosis. J Am Soc Nephrol (2009) 1.10
Renal hyperfiltration is a determinant of endothelial function responses to cyclooxygenase 2 inhibition in type 1 diabetes. Diabetes Care (2010) 1.08
Albumin activates ERK via EGF receptor in human renal epithelial cells. J Am Soc Nephrol (2005) 1.08
Activation of mesangial cell MAPK in response to homocysteine. Kidney Int (2004) 1.04
A molecular signature of proteinuria in glomerulonephritis. PLoS One (2010) 1.03
Enhanced susceptibility to biomechanical stress in ACE2 null mice is prevented by loss of the p47(phox) NADPH oxidase subunit. Cardiovasc Res (2011) 1.01
Using an electronic self-management tool to support patients with chronic kidney disease (CKD): a CKD clinic self-care model. Semin Dial (2013) 1.01
The impact of renin-angiotensin system polymorphisms on physiological and pathophysiological processes in humans. Curr Opin Nephrol Hypertens (2004) 0.97
Estradiol induces discordant angiotensin and blood pressure responses to orthostasis in healthy postmenopausal women. Hypertension (2005) 0.97
Canadian Society of Nephrology commentary on the 2012 KDIGO Clinical Practice Guideline for Anemia in CKD. Am J Kidney Dis (2013) 0.95
Lymphopenia and treatment-related infectious complications in ANCA-associated vasculitis. Clin J Am Soc Nephrol (2012) 0.94
Nitric oxide inhibits stretch-induced MAPK activation in mesangial cells through RhoA inactivation. J Am Soc Nephrol (2003) 0.94
The effect of direct renin inhibition alone and in combination with ACE inhibition on endothelial function, arterial stiffness, and renal function in type 1 diabetes. Diabetes Care (2012) 0.92
Searching for new biomarkers of renal diseases through proteomics. Clin Chem (2011) 0.92
Necrotizing glomerulonephritis caused by Bartonella henselae endocarditis. Am J Kidney Dis (2004) 0.92
Gender differences in renal responses to hyperglycemia and angiotensin-converting enzyme inhibition in diabetes. Kidney Int (2005) 0.92
Troponin I and T levels in renal failure patients without acute coronary syndrome: a systematic review of the literature. Can J Cardiol (2004) 0.92
The acute effect of clamped hyperglycemia on the urinary excretion of inflammatory cytokines/chemokines in uncomplicated type 1 diabetes: a pilot study. Diabetes Care (2010) 0.91
Effect of protein kinase Cbeta inhibition on renal hemodynamic function and urinary biomarkers in humans with type 1 diabetes: a pilot study. Diabetes Care (2008) 0.91
Hyperfiltration and effect of nitric oxide inhibition on renal and endothelial function in humans with uncomplicated type 1 diabetes mellitus. Am J Physiol Regul Integr Comp Physiol (2012) 0.91
Insights into the regulation of renal hemodynamic function in diabetic mellitus. Curr Diabetes Rev (2008) 0.91
Renal hemodynamic effect of cyclooxygenase 2 inhibition in young men and women with uncomplicated type 1 diabetes mellitus. Am J Physiol Renal Physiol (2008) 0.90
Age is a determinant of acute hemodynamic responses to hyperglycemia and angiotensin II in humans with uncomplicated type 1 diabetes mellitus. Am J Physiol Regul Integr Comp Physiol (2010) 0.90
Determinants of long-term graft outcome in transplant glomerulopathy. Transplantation (2010) 0.89
Effects of oral contraceptive use on the renal and systemic vascular response to angiotensin II infusion. J Am Soc Nephrol (2004) 0.89
Long-term hemodynamic and molecular effects persist after discontinued renin-angiotensin system blockade in patients with type 1 diabetes mellitus. Kidney Int (2013) 0.88
Adiponectin attenuates angiotensin II-induced oxidative stress in renal tubular cells through AMPK and cAMP-Epac signal transduction pathways. Am J Physiol Renal Physiol (2013) 0.88
Cystic adventitial pathology as an entity in peripheral arterial disease. J Cardiovasc Surg (Torino) (2015) 0.87
Interactions between gender and the angiotensin type 1 receptor gene polymorphism. Kidney Int (2003) 0.87
Loss of TIMP3 selectively exacerbates diabetic nephropathy. Am J Physiol Renal Physiol (2012) 0.86
Clinical value of inflammatory urinary biomarkers in overt diabetic nephropathy: a prospective study. Diabetes Res Clin Pract (2013) 0.86
Angiotensin-(1-7)-induced activation of ERK1/2 is cAMP/protein kinase A-dependent in glomerular mesangial cells. Am J Physiol Renal Physiol (2011) 0.86
Validating the oxford classification of IgA nephropathy. Clin J Am Soc Nephrol (2011) 0.85